Children and young adults treated with amiodarone have a significant likelihood for thyroid dysfunction soon after treatment initiation.
Pregnant women living near more oil and natural gas development activity have a greater chance of giving birth to children with congenital heart defects.
While pediatric patients with asthma may experience cardiac symptoms, they are rarely a sign of underlying cardiac disease.
Pediatric cardiac disease is associated with an increased risk for arterial ischemic stroke following cardiac procedures.
Children and young adult patients with congenital heart disease have an increased risk for developing cancer.
The FDA has approved Katerzia, a ready-to-use, oral suspension formulation of amlodipine.
Results of the study showed that the rate of symptomatic recurrent VTE – the primary end point – was similar in both treatment groups with 1.2% of patients experiencing a recurrent event in the rivaroxaban group compared with 3.0% in the standard anticoagulation group.
A scientific statement with recommendations for follow-up care in patients with Fontan circulation surviving into adulthood was published.
Increased BMI in adolescence is associated with an increased risk for cardiomyopathy in adulthood among men.
The FDA has approved Fragmin a low molecular weight heparin, for the treatment of symptomatic venous thromboembolism.